Technical Analysis for ABEO - Abeona Therapeutics Inc.

Grade Last Price % Change Price Change
grade F 6.55 0.92% 0.06
ABEO closed up 0.92 percent on Friday, May 24, 2019, on 88 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical ABEO trend table...

Date Alert Name Type % Chg
Lower Bollinger Band Walk Weakness 0.00%
Inside Day Range Contraction 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Stochastic Reached Oversold Weakness 0.92%
Below Lower BB Weakness 0.92%
Gapped Down Weakness 0.92%
Lower Bollinger Band Touch Weakness 0.92%
Oversold Stochastic Weakness 0.92%

Older signals for ABEO ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Abeona Therapeutics, Inc., formerly PlasmaTech Biopharmaceuticals, Inc., is focused on developing and delivering gene therapy and plasma-based products for severe and rare diseases. The Company's lead program includes adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB). Its product pipeline includes ABO-101 (sc AAV9 NAGLU), which is used for the treatment of MPS III B; ABO-102 (sc AAV9 SGSH), which is used for the treatment of MPS III A; ABO-201 (sc AAV9 CLN3), which is used for the treatment of Juvenile Batten Disease (JBD); ABO-301 (AAV LK19 FANCC), which is used for the treatment of Fanconi Anemia (FA), and clustered, regularly interspaced short palindromic repeats/CRISPR associated protein 9 (CRISPR/Cas9) gene editing, which is used for treatment of other rare blood diseases. The Company offers two platforms: Salt Diafiltration (SDF) Process and Polymer Hydrogel Technology (PHT).
Biotechnology Biology Emerging Technologies Gene Therapy Molecular Biology Genetics Genetic Engineering Genome Editing Adeno Associated Virus AAV Cas9 CRISPR Severe And Rare Diseases
Is ABEO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 18.9
52 Week Low 6.26
Average Volume 387,548
200-Day Moving Average 9.0025
50-Day Moving Average 7.6506
20-Day Moving Average 7.483
10-Day Moving Average 7.132
Average True Range 0.3811
ADX 21.5
+DI 10.5392
-DI 28.1746
Chandelier Exit (Long, 3 ATRs ) 7.2667
Chandelier Exit (Short, 3 ATRs ) 7.6298
Upper Bollinger Band 8.3576
Lower Bollinger Band 6.6084
Percent B (%b) -0.03
BandWidth 23.375651
MACD Line -0.2497
MACD Signal Line -0.1309
MACD Histogram -0.1188
Fundamentals Value
Market Cap 263.88 Million
Num Shares 40.3 Million
EPS -0.61
Price-to-Earnings (P/E) Ratio -10.74
Price-to-Sales 831.55
Price-to-Book 7.87
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.99
Resistance 3 (R3) 7.01 6.90 6.91
Resistance 2 (R2) 6.90 6.79 6.88 6.89
Resistance 1 (R1) 6.72 6.72 6.81 6.70 6.86
Pivot Point 6.61 6.61 6.65 6.59 6.61
Support 1 (S1) 6.43 6.50 6.52 6.41 6.24
Support 2 (S2) 6.32 6.43 6.30 6.21
Support 3 (S3) 6.14 6.32 6.19
Support 4 (S4) 6.12